Pittsburgh Journal of Technology Law & Policy

The Use of Race in Medical Artificial Intelligence

2021-09-21T15:15:02-04:00

The proliferated use of medical algorithms in health care has brought about medical innovation and improvements; however, there is a cost to a prevalent use of artificial intelligence in health care—exacerbating racism in the medicine. This Article examines the use of race in medical algorithms. Part II describes the development of medical AI, including its advantages and disadvantages. Part III focuses on how the use of medical algorithms may embed racism into our health care system. Part IV describes the FDA’s current regulations on medical AI. The Article concludes by advocating for legislation and regulations that work to reduce racial bias in medical algorithms.

For Profit or For Health? It is Time to Reckon With the Current Pharmaceutical Landscape Through a Systematic Analysis of Monoclonal Anitbodies

2021-09-21T15:15:02-04:00

Soaring drug prices are one of the greatest challenges facing the American healthcare system today. Major contributing factors include the extended use of market exclusivity granted by the FDA and the abuse of the Orphan Drug Act beyond its original purpose. This Note will discuss the regulatory and legislative history of the FDA from its inception to its current state and use a comprehensive analysis of monoclonal antibodies to highlight the practical effects high drug prices have on patient care. Finally, this Note will provide recommendations to shift the regulatory and legislative approach surrounding the FDA away from favoring innovation to supporting competition in the drug market, thus improving accessibility.

Volume XXI Issue 2 Front Matter

2021-09-21T15:15:02-04:00

Front Matter